Demographic Factors, Comorbidities and Symptoms Prevalent among Patients with COVID-19 in a Tertiary Health Institution in Nigeria
Journal of Advances in Medicine and Medical Research,
Background: Studies have suggested that patients’ medical data could be correlated with the disease outcome in individuals with COVID-19. There is however, paucity of data on the impact of many of these factors especially in rural and semi-urban environment in Nigeria.
Objective: This study seeks to establish the dynamics of patients tested for COVID-19 in a private tertiary facility located in a semi-urban area in Nigeria, with special focus on their symptoms, comorbidities, and demography.
Methods: The study was a retrospective study carried out using data generated by the Babcock Molecular and Tissue Culture Laboratory of Babcock University Teaching Hospital Ilisan-Remo, Ogun state between October 17, 2020 and July 20, 2021. Statistical analysis was carried out using Statistical Package for the Social Sciences version 21.0.
Result: Two thousand five hundred anonymized data were captured in the study. Under the period of review, only 9.5% of the entire tested population were positive to the SARS-CoV-2 virus. There was a significant relationship between age distribution, level of education and COVID-19 infection outcome (P < 0.05). Fever (42.6%) was the commonest symptom among the patient population while hypertension (34.6%) and diabetes (31.3%) were the leading comorbidities reported in this study.
Conclusion: Targeted approaches in the areas of tests and enlightenment for certain demographic groups such as those that are elderly and with low level of education is highly recommended.
- demographic factors
How to Cite
Soares RdCM, Mattos LR, Raposo LM. Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, Brazil. The American Journal of Tropical Medicine and Hygiene. 2020;103(3):1184–1190.
Bicheng Z, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLOS ONE. 2020;15(7):1–13.
Al-Najjar H, Al-Rousan N. A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea. Eur Rev Med Pharmacol Sci. 2020;24(6):3400–3403.
Barda N, Riesel D, Akriv A, Levy J, Finkel U, Yona G, et al. Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nature Communications. 2020;11(1):4439.
Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. The Journal of Clinical Endocrinology & Metabolism. 2020;105(8):2752–2761.
Colombi D, Bodini FC, Petrini M, Maffi G, Morelli N, Milanese G, et al. Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia. Radiology. 2020;296(2):E86–E96. pmid:32301647
Hu H, Yao N, Qiu Y. Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease. Academic Emergency Medicine. 2020;27(6):461–468.
Imam Z, Odish F, Gill I, O’Connor D, Armstrong J, Vanood A, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. Journal of Internal Medicine. 2020.
Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Critical Care. 2020;24(1):108. pmid:32188484
Yan L, Zhang HT, Goncalves J, Xiao Y, Wang M, Guo Y, et al. An interpretable mortality prediction model for COVID-19 patients. Nature Machine Intelligence. 2020;2(5):283–288.
Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLOS ONE. 2020;15(3):1–10. pmid:32191764
Zhao Z, Chen A, Hou W, Graham JM, Li H, Richman PS, et al. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLOS ONE. 2020;15(7):1–14.
Wang S, Zha Y, Li W, Wu Q, Li X, Niu M, et al. A Fully Automatic Deep Learning System for COVID-19 Diagnostic and Prognostic Analysis. European Respiratory Journal; 2020.
Yue H, Yu Q, Liu C, Huang Y, Jiang Z, Shao C, et al. Machine learning-based CT radiomics method for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study. Annals of translational medicine. 2020;8(14):859–859.
Liu X, Yue X, Liu F, Wei L, Chu Y, Bao H, et al. Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study. PLOS ONE. 2020;15(6):1–12.
Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328.
Rivera-Izquierdo M, del Carmen Valero-Ubierna M, R-delAmo JL, Fernandez-Garcıa MA, Martınez-Diz S, Tahery-Mahmoud A, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study. PLOS ONE. 2020;15(6):1–12.
Salako AO, Amoo OS, Odubela OO, Osuolale KA, James AB, Oladele DA, Musa AZ, Ige FA, Okwuraiwe AP, Onwuamah CK, Shaibu JO, David AN, Audu RA, Ezechi OC, Odunukwe NN, Salako BL. Prevalence and Clinical Characteristics of Coronavirus Disease 2019 Seen at a Testing Centre in Lagos Nigeria. West Afr J Med. 2021;38(1):54-58.
Covid19.who.int. 2022. Nigeria: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. [online]
World Health Organization. Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19): Interim guidance; 2020 (accessed August 4, 2020).
Erfani A, Shahriarirad R, Ranjbar K, Mirahmadizadeh A & Moghadami M. Knowledge, Attitude and Practice toward the Novel Coronavirus (COVID-19) Outbreak: A Population-Based Survey in Iran. [Preprint]. Bull World Health Organ. E-pub: 30 March 2020.
Alajmi J, Jeremijenkoa AM, Abrahama JC, Alishaqa M, Concepciona EG, Butta AA, Abou-Samra, A-B. COVID-19 Infection among Healthcare Workers in a National Healthcare System: The Qatar Experience. International Journal of Infectious Diseases. 2020;100:386-389.
Elimian KO, Ochu CL, Ilori E, Oladejo J, Igumbor E, Steinhardt L, Wagai J, et al. Descriptive Epidemiology of Coronavirus Disease 2019 in Nigeria, 27 February-6 June 2020. Epidemiology and Infection. 2020;148:e208.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 May 14; 55(5):2000547
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059.
Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, et al. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS ONE. 2021;16(3):e0248281
National Research Council. The Continuing Epidemiological Transition in subSaharan Africa: A Workshop Summary. Thomas J. Plewes and Kevin Kinsella, Rapporteurs. Committee on National Population, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press; 2012.
Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria. J Hypertens. 2015;33(2):230– 242.
Uloko AE, Musa BM, Ramalan MA, Gezawa ID, Puepet FH, Uloko AT, et al. Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Ther. 2018; 9(3):1307–1316.
Vincent-Onabajo G, Mohammad HS, Umeonwuka C. Prevalence of undiagnosed hypertension among a cohort of university workers in Nigeria. Int J Community Med Public Health. 2016;3(7): 1963–1967.
Abstract View: 99 times
PDF Download: 20 times